“A common theme here is that the data exists, but it has been ignored or beaten back,” says science journalist Linda Villarosa. At the Aspen Ideas Festival, TEDWomen co-host Pat Mitchell (at right) led a conversation about challenges around getting fair and equitable health care for women. The panel included, from left, journalist Villarosa, Dr. Deborah Rhodes of the Mayo Clinic and Dr. Paula Johnson, president of Wellesley College.

TEDWomen co-host Pat Mitchell writes: Once again this summer, I had the privilege of moderating sessions during the Spotlight Health Aspen Institute Ideas Festival. There were some surprises in a session titled “Breakthroughs and Challenges in Women’s Health” with importance for all women, and I want to share some of that information with you.

With two esteemed physicians — Dr. Deborah Rhodes of the Mayo Clinic and Dr. Paula Johnson, who was chief of women’s health at Brigham and Women’s Hospital at Harvard University and is now the president of Wellesley College — as well as science journalist Linda Villarosa, we began our conversation with the important reminder that improving health care depends in large part on research.

We don’t know what we don’t look for

Despite legislation passed over 20 years ago, women, and especially women of color, are still being left out of clinical trials, and the health outcomes for women, and especially women of color, reflect this disparity.

Dr. Paula Johnson talked about the disparity between the resources for research on men’s diseases and those specific to women in her 2014 TEDWomen talk — and if you haven’t seen it, I highly encourage you to watch it.

Dr. Johnson explained that every cell in the human body has a sex, which means that men and women are different right down to the cellular level! As a result, there are often significant differences in the ways in which men and women respond to disease or treatment. It’s very important in research trials to differentiate between female and male subjects so we can tease out the differences.

Although we have made progress since the 1990s with more women included in late-phase trials, we’re still not there in phases 1 and 2. This is important, she says, because how do we get to phase 3? Phases 1 and 2. In these early stages of research, female cells and female animals still aren’t being used. Why? She says one commonly cited reason is that female animals have an estrous cycle. Well, guess what, she says, so do we. What are we missing by not including female cells earlier in the research process?

The power and persistence of the status quo

One of the barriers to progress that perhaps we don’t think about as much is the problem with well-entrenched power paradigms, profit motives and institutional priorities. What happens when a doctor sees a need and solves it but the status quo is preferred over progress?

Dr. Deborah Rhodes — whose talk above from TEDWomen 2010 is a must — spoke about the challenges to her attempts to introduce a new diagnostic protocol for women with dense breasts. Dr. Rhodes (who in spirit of full disclosure is my personal physician at the Mayo Clinic) has observed in her practice that about 50% of women were potentially missing a cancer diagnosis because traditional mammograms fail in detecting breast cancer in women with dense breasts. Mammograms depend on visually seeing cancer cells, and in dense breasts this is more difficult because of the surrounding dense tissue.

As Dr. Rhodes says, in looking at entrenched paradigms in medicine, there is perhaps nothing more entrenched than the mammogram. She worked with physicists to come up with a new way to look for tumors using a tracer that has been safely used in cardiovascular medicine for decades that distinguishes tumor cells regardless of density. Her technique is FDA-approved, but you’ve probably never heard of it. It speaks to, as she says, “the extraordinary difficulties of upsetting something that is so precious to us as a mammogram.”

Earlier detection using her new test in women with dense breasts whose cancer may be hidden in a mammogram could spare women from toxic treatment (less advanced cancer means less chemotherapy) and, in more advanced cases, saving lives. Despite that, her research has been very, very difficult to fund. She says it’s a daily uphill battle to overturn the status quo. Doctors have invested years and years in learning how to read these difficult mammograms, and billions of dollars are invested in the current technology, resulting in a resistance to new technology and new ways of testing.

Intersection of gender, race and ethnicity

One of the more shocking statistics that Dr. Rhodes highlighted in her presentation was the disparity in outcomes for white women and women of color with breast cancer. White women are more likely to get breast cancer than black women, but black women are more likely to die of breast cancer. She says that is true particularly for black women under the age of 50 who are diagnosed with breast cancer. They are 77% more likely to die than white women. She points out that despite abundant data that informs us of these disparities, solutions are not being pursued.

The same tragic disparity between what we need to know for better health outcomes and what is fully understood as life and death factors was the subject of Linda Villarosa’s recent cover story in the New York Times Magazine titled “Why America’s Black Mothers and Babies Are in a Life-or-Death Crisis.” In her incredible article, she noted that black women were three-to-four times as likely to die in childbirth than white women and black babies die at a rate that is twice that of white babies.

Linda was one of the first journalists to put the maternal and infant mortality rates together and to investigate why black women and babies are so at risk. As she put it: “A common theme here is that the data exists, but it has been ignored or beaten back.” And further, she connected a condition identified earlier by Dr. Arline Geronimus called “weathering” that is a significant factor in the health outcomes for women of color. “The effect of racism — living with the near daily episodes of microaggressions and discriminations — have an adverse impact on health that needs to be better understood and incorporated into diagnosis and treatment for women of color.”

Shocking, yes, and deeply disturbing, but the good news is that the more we know about our own health and what impacts it adversely, the more proactive we can be as health consumers.

As one of the panelists noted to this highly engaged audience at Aspen Institute, “Nothing less than our lives depends on being informed and demanding that our health care institutions and physicians are, too.”

You can listen to the entire panel on aspenideas.org.

– Pat

TEDWOMEN 2018 UPDATE

The theme for this year’s TEDWomen event is “Showing Up.” We’re planning three inspiring days of ideas and connections full of creators, connectors and leaders. These dynamic and diverse pioneers are facing challenges head on and shaping the future we all want to see. If you haven’t been before, this is the year to show up!

I hope you’ll join us in Palm Springs Nov. 28–30, 2018. Registration is filling up fast and I don’t want you to miss out, so click this link to apply to attend today.